PAIRE™ acts as a safety net in the interpretation of PET/CT examinations and provides access to new clinical indicators such as TMTV.
PAIRE™ is an artificial intelligence solution that supports nuclear physicians in their decision making.Once PET and CT series are acquired, PAIRE™ detects and segments lesions on PET-CT scans to extract features usually reported in reports.
A MIP (Maximum Intensity Projection) which is a 2D projection of the 3D PET series with the lesions highlighted
A series of PET scans showing only the pathological lesions
A series containing the key images (coronal, sagittal and axial fusion, and coronal PET) of each lesion detected
Save time, secure your diagnosis and optimise your workflow with Incepto
- Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network. EJNMMI 2021 DOI: 10.1007/s00259-020-05080-7
- Prognostic value of anthropometric measures extracted from whole body CT using deep learning in patients with non-small cell lung cancer. European Radiology 2020 DOI: 10.1007/s00259-020-05080-7
- Automatic lesion detection and segmentation of 18f-FET PET in gliomas: A full 3d U-Net convolutional neural network study. JNM 2018 DOI: 10.1007/s00259-020-05080-7
As a leader in the field of artificial intelligence applied to nuclear medicine, PAIRE implements a local server capable of assisting you in the interpretation of your FDG PET scans to increase awareness of abnormalities, estimate metabolic volumes and much more. The data is not stored or sent to remote servers, you remain in control.
The PaIRe medical device is a regulated health product that carries the CE mark, Class I. Manufacturer: IB PaIRe.PaIRe is a diagnostic tool and should not be used alone to recommend medical management for diagnostic purposes. Please read the instructions in the user manual carefully. Please email@example.com for more information. Last update :15/03/2022